Order Article Reprints

Lin T-H, Gao H-W, Liao G-S, Yu J-C, Dai M-S, Ho J-Y, Yu C-P. Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor. Cancers. 2021; 13(4):905. https://doi.org/10.3390/cancers13040905

Lin, Tai-Han, Hong-Wei Gao, Guo-Shiou Liao, Jyh-Cherng Yu, Ming-Shen Dai, Jar-Yi Ho, and Cheng-Ping Yu. 2021. "Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor" Cancers 13, no. 4: 905. https://doi.org/10.3390/cancers13040905

Lin, T.-H., Gao, H.-W., Liao, G.-S., Yu, J.-C., Dai, M.-S., Ho, J.-Y., & Yu, C.-P. (2021). Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor. Cancers, 13(4), 905. https://doi.org/10.3390/cancers13040905